{"id":206609,"name":"CLINICAL REFERENCE LABORATORY, INC.","slug":"clinical-reference-laboratory-inc","state":"KS","country":"United States of America","description":"privately held clinical testing laboratory","totalSpending":500000,"filings":24,"yearlySpending":[{"year":2020,"income":120000},{"year":2021,"income":240000},{"year":2022,"income":60000},{"year":2023,"income":0},{"year":2024,"income":0},{"year":2025,"income":80000}],"issues":[{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"HCR","display":"Health Issues"}],"firms":["VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC)"],"lobbyists":["KEVIN YODER"],"govEntities":["Food & Drug Administration (FDA)","SENATE","Veterans Affairs, Dept of (VA)","HOUSE OF REPRESENTATIVES","Transportation, Dept of (DOT)"],"sampleDescriptions":["FDA approval process of COVID-19 related medical device.","FDA approval process of COVID-19 related medical device and COVID-19 testing solutions.","FDA approval process of COVID-19 related medical device and COVID-19 testing solutions; H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus","FDA approval process of COVID-19 related medical device and COVID-19 testing solutions.","FDA approval process of COVID-19 related medical device and COVID-19 testing solutions."]}